
BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.
BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...





